Welcome
The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients
with type 1 diabetes.
Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes.
The network includes the following centers...
University of Miami
Miami, Florida
University of Minnesota
Minneapolis, Minnesota
University of Pennsylvania
Philadelphia, Pennsylvania
Emory University
Atlanta, Georgia
Northwestern University
Chicago, Illinois
University of Alberta
Edmonton, Alberta, Canada
University of California
San Francisco, California
University of Illinois at Chicago
Chicago, Illinois
University of Wisconsin
Madison Wisconsin
Uppsala University
Uppsala, Sweden
University Hospital Rikshospitalet
Oslo, Norway
Karolinska University
Stockholm, Sweden
Massachusetts General Hospital
Boston, Massachusetts
